These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 18485021)
1. Diffuse large B-cell lymphoma in a patient with rheumatoid arthritis treated with infliximab and methotrexate. Nakashima C; Tanioka M; Takahashi K; Miyachi Y Clin Exp Dermatol; 2008 Jul; 33(4):437-9. PubMed ID: 18485021 [TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis. Fam AG; Perez-Ordonez B; Imrie K J Rheumatol; 2000 Jun; 27(6):1546-9. PubMed ID: 10852288 [TBL] [Abstract][Full Text] [Related]
3. [Case report: RAEB in a patient with rheumatoid arthritis treated with methotrexate and infliximab]. D'Alessandro G; Bianco MR; Politis S; Ferrandina C; Rossi G; Altomare E Reumatismo; 2006; 58(1):59-61. PubMed ID: 16639489 [TBL] [Abstract][Full Text] [Related]
4. Sézary syndrome in a patient receiving infliximab for ankylosing spondylitis. Dauendorffer JN; Rivet J; Allard A; Bachelez H Br J Dermatol; 2007 Apr; 156(4):742-3. PubMed ID: 17263820 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Thonhofer R; Gaugg M; Kriessmayr M; Neumann HJ; Erlacher L Ann Rheum Dis; 2005 Jul; 64(7):1098-9. PubMed ID: 15958773 [No Abstract] [Full Text] [Related]
6. [A case of rheumatoid arthritis with malignant lymphoma taking methotrexate]. Hayakawa M; Morita T Ryumachi; 1995 Aug; 35(4):678-82. PubMed ID: 7482065 [TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Geborek P; Bladström A; Turesson C; Gulfe A; Petersson IF; Saxne T; Olsson H; Jacobsson LT Ann Rheum Dis; 2005 May; 64(5):699-703. PubMed ID: 15695534 [TBL] [Abstract][Full Text] [Related]
8. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Wolfe F; Michaud K Arthritis Rheum; 2007 May; 56(5):1433-9. PubMed ID: 17469100 [TBL] [Abstract][Full Text] [Related]
9. Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient. Mo N; Muthu S; O'Sullivan M Rheumatology (Oxford); 2011 Apr; 50(4):808-10. PubMed ID: 21183450 [No Abstract] [Full Text] [Related]
10. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases. Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017 [No Abstract] [Full Text] [Related]
11. [Infliximab in the treatment of rheumatoid arthritis]. Akahoshi T; Watabe H Nihon Rinsho; 2002 Dec; 60(12):2378-83. PubMed ID: 12510365 [TBL] [Abstract][Full Text] [Related]
12. Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. Quartuccio L; De Re V; Fabris M; Marzotto A; Franzolini N; Gasparotto D; Caggiari L; Ferraccioli G; Scott CA; De Vita S Haematologica; 2006 May; 91(5):691-4. PubMed ID: 16670074 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy in a rheumatoid arthritis patient on infliximab and methotrexate. Kinder AJ; Edwards J; Samanta A; Nichol F Rheumatology (Oxford); 2004 Sep; 43(9):1195-6. PubMed ID: 15317958 [No Abstract] [Full Text] [Related]
16. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713 [TBL] [Abstract][Full Text] [Related]
17. Composite cutaneous lymphoma in a patient with rheumatoid arthritis treated with methotrexate. Huwait H; Wang B; Shustik C; Michel RP Am J Dermatopathol; 2010 Feb; 32(1):65-70. PubMed ID: 20098085 [TBL] [Abstract][Full Text] [Related]
18. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Cöster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N Ann Rheum Dis; 2009 May; 68(5):648-53. PubMed ID: 18467516 [TBL] [Abstract][Full Text] [Related]
19. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab. Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618 [TBL] [Abstract][Full Text] [Related]
20. Multiple malignant melanomas in a patient with RA treated with methotrexate. Potter T; Hardwick N; Mulherin D J Rheumatol; 1998 Nov; 25(11):2282-3. PubMed ID: 9818680 [No Abstract] [Full Text] [Related] [Next] [New Search]